v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Jul. 29, 2022
Jul. 30, 2021
Jul. 31, 2020
Cash flows from operating activities:      
Net income (loss) $ 131,880 $ 254,513 $ (32,475)
Net loss from unconsolidated subsidiary 0 0 142,442
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 103,568 108,604 118,178
Amortization of debt discount and issuance costs 1,755 864 0
Loss on disposition of property and equipment 5,637 4,064 6,469
Gain on sale and leaseback transactions 0 (217,722) (69,954)
Impairment 0 0 23,160
Share-based compensation 8,198 8,729 6,386
Noncash lease expense 58,498 55,817 63,442
Amortization of asset recognized from gain on sale and leaseback transactions 12,735 12,735 0
Changes in assets and liabilities:      
Accounts receivable (2,039) (7,016) 3,124
Income taxes receivable 18,672 7,729 (19,403)
Inventories (74,929) 771 16,094
Prepaid expenses and other current assets (2,771) (3,538) 401
Other assets 8,459 (3,997) (5,638)
Accounts payable 34,695 31,672 (30,593)
Current operating lease liabilities 4,120 8,150 (11,269)
Taxes withheld and accrued 12,181 16,854 (7,019)
Accrued employee compensation (13,129) 8,472 (11,573)
Accrued employee benefits 1,278 (653) (550)
Deferred revenues 458 (1,605) 13,028
Other current liabilities (6,591) 2,791 6,868
Long-term operating lease liabilities (59,227) (59,388) (48,854)
Other long-term obligations (32,048) 6,919 10,673
Deferred income taxes (6,147) 67,138 (11,935)
Net cash provided by operating activities 205,253 301,903 161,002
Cash flows from investing activities:      
Purchase of property and equipment (98,341) (71,409) (297,328)
Proceeds from insurance recoveries of property and equipment 1,237 1,279 1,320
Proceeds from sale of property and equipment 105 149,960 207,253
Notes receivable from unconsolidated subsidiary 0 0 (35,500)
Acquisition of business, net of cash acquired (1,500) (1,500) (32,971)
Net cash provided by (used in) investing activities (98,499) 78,330 (157,226)
Cash flows from financing activities:      
Proceeds from issuance of long-term debt 230,000 60,000 801,395
Proceeds from issuance of convertible senior notes 0 291,605 0
Taxes withheld from issuance of share-based compensation awards (2,599) (2,282) (2,160)
Principal payments under long-term debt (185,124) (924,572) (252,000)
Proceeds from issuance of warrants 0 31,710 0
Purchase of convertible note hedge 0 (62,010) 0
Purchases and retirement of common stock (131,542) (35,000) (55,007)
Deferred financing costs (2,148) (420) (1,348)
Dividends on common stock (114,829) (31,667) (94,544)
Net cash provided by (used in) financing activities (206,242) (672,636) 396,336
Net increase (decrease) in cash and cash equivalents (99,488) (292,403) 400,112
Cash and cash equivalents, beginning of year 144,593 436,996 36,884
Cash and cash equivalents, end of year 45,105 144,593 436,996
Cash paid during the year for:      
Interest, net of amounts capitalized 7,698 40,802 20,268
Income taxes 25,948 2,907 5,666
Supplemental schedule of non-cash investing and financing activities:      
Capital expenditures accrued in accounts payable 7,421 5,806 1,691
Change in fair value of interest rate swaps 0 27,110 (17,740)
Change in deferred tax asset for interest rate swaps 0 (6,764) 4,307
Dividends declared but not yet paid $ 30,456 $ 24,157 $ 32,063